title: Treating stroke in the 21st century.
authors.forename: Roxana
authors.initials: R
authors.lastname: Oprisiu
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Serot
authors.forename: Sandra E
authors.initials: SE
authors.lastname: Black
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Achard
authors.forename: Albert
authors.initials: A
authors.lastname: Fournier
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D001713:Biphenyl Compounds; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D020521:Stroke / Q000188:drug therapy*; D013777:Tetrazoles / Q000627:therapeutic use*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D013777:Tetrazoles; D004921:Erythropoietin; C081643:candesartan